Hydroxypropyl Methylcellulose (HPMC) Capsules Market is Projected to Reach USD 1083.24 billion by 2031

The global Hydroxypropyl Methylcellulose (HPMC) capsules market has been experiencing significant growth and transformation. In 2023, the market size reached a substantial USD 607.38 million. Moving forward, MarketsGlob projects that the market will continue to expand, reaching an impressive USD 1083.24 million by 2031. This anticipated growth, at a robust Compound Annual Growth Rate (CAGR) of 7.5% from 2024 to 2031, underscores the dynamic nature of the industry.

Key Players Shaping the Market

The HPMC capsules market features a diverse array of prominent players who are driving innovation and expanding their market footprints. These include:

  • Capsugel (Lonza)
  • ACG Associated Capsules
  • Qualicaps
  • Shanxi GS Capsule
  • CapsCanada
  • Suheung Capsule
  • Qingdao Capsule
  • Lefan Capsule
  • Sunil Healthcare
  • Bright Pharma Caps Inc.
  • Natural Capsules Limited
  • HealthCaps India Ltd.
  • Roxlor LLC
  • Medi-Caps Ltd.
  • Pharmax Pharmaceuticals FZE
  • Zhejiang Yuexi Capsule Co. Ltd.
  • BioCaps Enterprise
  • Bright Caps GmbH
  • Excellent Health Products Co. Ltd.
  • Farmacapsulas S.A.
  • Shanghai Honest Chem Co. Ltd.
  • Shaoxing Kangke Capsule Co. Ltd.
  • Wuhan Carma Technology Co. Ltd.
  • Others

Market Segmentation

The market is segmented based on types, applications, and sales channels, as well as geographically. Here’s a closer look:

  • Types Covered:
    • HPMC with Gelling Agent
    • HPMC without Gelling Agent
  • Applications Covered:
    • Pharmaceutical
    • Health Supplements
    • Others
  • Sales Channels Covered:
    • Direct Channel
    • Distribution Channel
  • Regions Covered:
    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East and Africa

Strategic Movements in the Market

The HPMC capsules market has witnessed several strategic acquisitions and investments that highlight its growth trajectory and competitive landscape. Notable transactions include:

  1. Acquisition on 9 Aug 2021: Advent International, a leading private equity investor, acquired a majority ownership interest in Shanxi Guangsheng Medicinal Capsule Co., Ltd (GS Capsule), the largest domestic capsule provider in China. This acquisition was made from Meihua Holdings Group and co-investors, signifying Advent’s strategic move to strengthen its position in the burgeoning Chinese market.
  2. Investment on 23 Nov 2021: ACG, a global supplier to the pharma industry, announced a significant investment of INR 600 crore to establish Asia’s largest capsule manufacturing unit near Aurangabad, Maharashtra, India. This new facility, which will produce 40 billion capsules annually, includes a research and development center and aims to serve both domestic and international pharma and nutraceutical companies.
  3. Acquisition on 10 Jul 2023: ACG expanded its packaging solutions by acquiring Technical Aluminum Foil Company (TAFC) in the United Arab Emirates. This acquisition bolsters ACG’s comprehensive packaging solutions, particularly in the Middle Eastern and African markets, with TAFC specializing in high-barrier packaging used in both the pharmaceutical and food industries.
  4. Acquisition on 23 Oct 2023: Roquette, a leader in plant-based ingredients and pharmaceutical excipients, completed the acquisition of Qualicaps from the Mitsubishi Chemical Group. Qualicaps, the third largest producer of hard capsules for oral dosage solutions, enhances Roquette’s market position with its high-quality products and innovative pipeline. This acquisition supports Roquette’s global expansion, increasing its workforce to around 10,000 employees across more than 100 countries.

The global HPMC capsules market is poised for substantial growth, driven by innovations, strategic acquisitions, and expanding applications in the pharmaceutical and health supplement sectors. Key players continue to shape the market dynamics, ensuring a competitive and evolving landscape. As the market moves towards an anticipated value of USD 1083.24 million by 2031, stakeholders can look forward to a period of robust growth and exciting opportunities.

Please connect with our sales team (sales@marketsglob.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1 (210) 807 3402 to share your research requirements.